HKBNF yields 11.00% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, HKBNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HKBNF + PFE for your $10,000?
HKBN Ltd., an investment holding company, provides fixed telecommunications network, international telecommunications, and mobile services to residential and enterprise customers in Hong Kong. It offers broadband, data connectivity, cloud and data center, managed Wi-Fi, business continuity, system integration, cybersecurity, mobile, and voice and collaboration services; and roaming and digital solutions, as well as stationery and supplies for Transformation as a Service (TaaS) and OTT entertainment. The company provides IT and security, data processing and center, telecommunication, administrative support, consulting, enterprise systems, technical and product sale, distribution and logistics, outsourcing, Wi-Fi consultancy and connectivity, and business referrals and consultancy services. It also offers internet, telecommunications, and security devices installation services; holds and invests in properties; sells and markets mirapoint, and email related products; holds licenses; and markets and distributes computer hardware and software, and telecommunication and office automation products, as well as provides related services. The company was founded in 1992 and is headquartered in Kwai Chung, Hong Kong.
Full HKBNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.